https://cancernetus.com/educational-activities/ 2026-03-17T07:24:20+00:00 https://cancernetus.com/product/emerging-strategies-in-novel-targeted-therapies-for-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-bladder-carcinoma/ 2025-09-23T23:22:26+00:00 https://cancernetus.com/wp-content/uploads/2018/09/GettyImages-499577942-1.jpg https://cancernetus.com/product/new-paradigms-in-the-treatment-of-acute-lymphoblastic-leukemia-chronic-lymphocytic-leukemia-acute-myeloid-leukemia-and-chronic-myeloid-leukemia/ 2025-10-01T15:26:20+00:00 https://cancernetus.com/wp-content/uploads/2018/12/GettyImages-2222698522-1.jpg https://cancernetus.com/product/changing-treatment-paradigms-with-immunotherapy-and-targeted-therapy-in-advanced-non-small-cell-lung-cancer-and-head-neck-cancer/ 2025-10-01T15:36:09+00:00 https://cancernetus.com/wp-content/uploads/2018/10/99f05264-155f-44df-b241-d0e87bea2eeb.webp https://cancernetus.com/product/pi3k-akt-mtor-pathway-inhibitors-in-the-treatment-of-hr-her2-metastatic-breast-cancer-2-enduring-webcast/ 2025-10-22T17:54:26+00:00 https://cancernetus.com/wp-content/uploads/2025/10/Enduring-800-x-450.png https://cancernetus.com/product/advances-in-the-treatment-of-diffuse-large-b-cell-lymphoma-adcs-bispecific-antibodies-car-t-therapies-and-combinations-enduring-webcast/ 2025-10-22T17:56:32+00:00 https://cancernetus.com/wp-content/uploads/2025/08/pkrsqa77g4qf-Banner-800x450-1.jpg https://cancernetus.com/product/ovarian-cancer-optimizing-the-management-based-on-mutations-and-biomarkers-to-direct-treatment-with-parp-inhibitors-and-immunotherapy-enduring-webcast/ 2025-10-22T17:58:18+00:00 https://cancernetus.com/wp-content/uploads/2025/08/fzrp9upi54v9-Banner-800x450-1.jpg https://cancernetus.com/product/ovarian-cancer-optimizing-the-management-based-on-mutations-and-biomarkers-to-direct-treatment-with-parp-inhibitors-and-immunotherapy-2-live/ 2025-10-22T17:58:30+00:00 https://cancernetus.com/wp-content/uploads/2025/08/8df5pczcuyjg-Banner800x450.png https://cancernetus.com/product/evolving-paradigm-of-parp-inhibitors-and-combination-therapies-for-mcrpc-enduring-webcast/ 2025-10-22T17:59:37+00:00 https://cancernetus.com/wp-content/uploads/2025/08/t4r5wlxkt5fm-ProstateCancer_800x450.png https://cancernetus.com/product/emerging-strategies-in-the-immune-checkpoint-inhibitors-icis-and-the-synergistic-effect-of-antibody-drug-conjugate-in-combination-with-icis-for-urothelial-carcinoma-enduring-webcast/ 2025-10-22T18:01:02+00:00 https://cancernetus.com/wp-content/uploads/2025/08/i8o0sqi8271n-800x450_Endur.jpg https://cancernetus.com/product/hepatocellular-carcinoma-immune-checkpoint-inhibitors-multi-targeted-tyrosine-kinase-inhibitors-and-the-combination-thereof-enduring-webcast/ 2025-10-22T18:01:19+00:00 https://cancernetus.com/wp-content/uploads/2025/08/eqaytv2csn9x-OverviewPg800x450Endur.png https://cancernetus.com/product/advances-in-symptom-burden-risk-stratification-and-treatment-of-myelofibrosis-enduring-webcast/ 2025-10-22T18:01:35+00:00 https://cancernetus.com/wp-content/uploads/2025/08/9ebzht8qyfa7-OveviewPg_800x450.png https://cancernetus.com/product/advances-in-symptom-burden-risk-stratification-and-treatment-of-myelofibrosis-2-live/ 2025-10-22T18:01:46+00:00 https://cancernetus.com/wp-content/uploads/2025/08/39c6wt89wb4q-Oveviewpg_800x450.png https://cancernetus.com/product/new-strategies-in-the-diagnosis-and-treatment-of-follicular-lymphoma-2022-ash-update-enduring-webcast/ 2025-10-22T18:02:04+00:00 https://cancernetus.com/wp-content/uploads/2025/08/vpkjhzyqldzs-Overview800x450Endur.png https://cancernetus.com/product/emerging-strategies-in-the-treatment-of-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-carcinoma-enduring-webcast/ 2025-10-22T18:02:22+00:00 https://cancernetus.com/wp-content/uploads/2025/08/amliakw56epk-Oveview-pg-800x450-Endur.jpg https://cancernetus.com/product/ovarian-cancer-mutations-biomarkers-and-treatment-with-parp-inhibitors-and-immunotherapy-enduring-webcast/ 2025-10-22T18:03:57+00:00 https://cancernetus.com/wp-content/uploads/2025/08/rujsa6hhfson-800x450-1.jpg https://cancernetus.com/product/ovarian-cancer-mutations-biomarkers-and-treatment-with-parp-inhibitors-and-immunotherapy-2-live/ 2025-10-22T18:04:10+00:00 https://cancernetus.com/wp-content/uploads/2025/08/54snckqsglqt-Oveviewpage800x450.png https://cancernetus.com/product/immune-checkpoint-and-braf-mek-inhibitor-directed-therapies-for-advanced-melanoma-enduring-webcast/ 2025-10-22T18:07:21+00:00 https://cancernetus.com/wp-content/uploads/2025/08/j7eazgrqndc8-800x450_Endur.jpg https://cancernetus.com/product/immune-checkpoint-and-braf-mek-inhibitor-directed-therapies-for-advanced-melanoma-2-live/ 2025-10-22T18:08:33+00:00 https://cancernetus.com/wp-content/uploads/2025/08/qhhfegjft6k4-OveviewPg800x450.png https://cancernetus.com/product/improving-renal-cell-carcinoma-patient-outcomes-with-multi-targeted-tkis-and-immune-checkpoint-inhibitors-2-live/ 2025-10-22T18:09:16+00:00 https://cancernetus.com/wp-content/uploads/2025/08/4dwaqzz0z1ja-Oveviewpg800x450.png https://cancernetus.com/product/current-and-emerging-treatment-options-for-multiple-myeloma-live/ 2025-10-22T18:11:03+00:00 https://cancernetus.com/wp-content/uploads/2025/08/4674y79gpsjn-MM_800x450.jpg https://cancernetus.com/product/novel-treatment-options-for-multiple-myeloma-2-live/ 2025-10-22T18:11:15+00:00 https://cancernetus.com/wp-content/uploads/2025/08/nq9z3i2wlgxv-Oveviewpg800x450.png https://cancernetus.com/product/novel-therapies-for-metastatic-castrate-resistant-prostate-cancer-with-parp-inhibitors-and-bite-immunotherapy-2-live/ 2025-10-22T18:11:35+00:00 https://cancernetus.com/wp-content/uploads/2025/08/gld8ie5n0zaq-800x450-1.png https://cancernetus.com/product/emerging-treatment-options-for-braf-mutant-colorectal-cancer-2-live/ 2025-10-22T18:11:46+00:00 https://cancernetus.com/wp-content/uploads/2025/08/kfsazn6otsg3-BRAF_CRC_800x450.jpg https://cancernetus.com/product/changing-landscape-of-treatment-for-acute-lymphoblastic-leukemia-2-live/ 2025-10-22T18:12:02+00:00 https://cancernetus.com/wp-content/uploads/2025/08/xtkwnby768my-Endur-800x450-1.jpg https://cancernetus.com/product/biosimilars-implications-for-clinical-practice-in-hematological-malignancies-supportive-care-2-live/ 2025-10-22T18:12:14+00:00 https://cancernetus.com/wp-content/uploads/2025/08/kdm0lnmyxr9z-OverviewPg800x450.jpg https://cancernetus.com/product/update-on-the-immune-checkpoint-inhibitor-and-combination-targeted-therapies-for-hepatocellular-carcinoma-2-live/ 2025-10-22T18:12:26+00:00 https://cancernetus.com/wp-content/uploads/2021/03/b76ocg8gtlzx-Norton-UnderstandingInfectiousDiseases-1386962536_800x385.jpg https://cancernetus.com/product/changing-landscape-of-nsclc-with-targeted-therapies-and-immunotherapy-2-live/ 2025-10-22T18:12:37+00:00 https://cancernetus.com/wp-content/uploads/2020/11/GettyImages-2182528876-1.jpg https://cancernetus.com/product/advances-in-the-treatment-of-dmmr-msi-h-colorectal-cancer-with-immunotherapy-2-live/ 2025-10-22T18:12:58+00:00 https://cancernetus.com/wp-content/uploads/2020/11/GettyImages-2150646180-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-multiple-myeloma-live/ 2025-10-22T18:13:07+00:00 https://cancernetus.com/wp-content/uploads/2020/09/GettyImages-2159300281-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-hematological-malignancies-2-live/ 2025-10-22T18:13:17+00:00 https://cancernetus.com/wp-content/uploads/2020/09/GettyImages-1748497667-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-renal-cell-carcinoma-2-live/ 2025-10-22T18:13:30+00:00 https://cancernetus.com/wp-content/uploads/2020/08/GettyImages-2162066476-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-lung-cancer-and-head-neck-cancer-2-live/ 2025-10-22T18:13:41+00:00 https://cancernetus.com/wp-content/uploads/2020/07/GettyImages-157609390-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-carcinoma-2-live/ 2025-10-22T18:13:51+00:00 https://cancernetus.com/wp-content/uploads/2020/06/GettyImages-1406337730-1.jpg https://cancernetus.com/product/improving-renal-cell-carcinoma-patient-outcomes-with-multi-targeted-tkis-and-immune-checkpoint-inhibitors-enduring/ 2025-10-22T18:16:09+00:00 https://cancernetus.com/wp-content/uploads/2025/08/4fo4e827g73f-Oveview-800x450-Enudur.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-multiple-myeloma-2-live/ 2025-10-22T18:16:55+00:00 https://cancernetus.com/wp-content/uploads/2025/08/ajx2im0798rb-Oveviewpg800x450.png https://cancernetus.com/product/novel-treatment-options-for-multiple-myeloma-enduring/ 2025-10-22T18:17:38+00:00 https://cancernetus.com/wp-content/uploads/2025/08/odds0u1hmcb4-800x450-Enduring.jpg https://cancernetus.com/product/new-and-emerging-treatment-options-for-hematological-malignancies-enduring/ 2025-10-22T18:17:56+00:00 https://cancernetus.com/wp-content/uploads/2025/08/igfq1tqa5pgz-800x450-1.jpg https://cancernetus.com/product/evolving-strategies-in-the-treatment-of-her2-positive-metastatic-breast-cancer-with-antibody-drug-conjugates-and-tyrosine-kinase-inhibitors-enduring-webcast/ 2025-10-22T18:24:54+00:00 https://cancernetus.com/wp-content/uploads/2025/08/jnc4hpjroznm-Oveviewpg800x450.png https://cancernetus.com/product/emerging-treatment-options-for-chronic-lymphocytic-leukemia-and-mantle-cell-lymphoma-2-live/ 2025-10-22T18:26:33+00:00 https://cancernetus.com/wp-content/uploads/2025/08/ohfs1xt284l5-Oveviewpg800x450.png https://cancernetus.com/product/novel-therapies-for-metastatic-castrate-resistant-prostate-cancer-with-parp-inhibitors-and-bite-immunotherapy-enduring-webcast/ 2025-10-22T18:27:30+00:00 https://cancernetus.com/wp-content/uploads/2025/08/gld8ie5n0zaq-800x450-1.png https://cancernetus.com/product/emerging-treatment-options-for-braf-mutant-colorectal-cancer-enduring-webcast/ 2025-10-22T18:28:04+00:00 https://cancernetus.com/wp-content/uploads/2025/08/kfsazn6otsg3-BRAF_CRC_800x450.jpg https://cancernetus.com/product/changing-landscape-of-treatment-for-acute-lymphoblastic-leukemia-enduring-webcast/ 2025-10-22T18:28:16+00:00 https://cancernetus.com/wp-content/uploads/2025/08/xtkwnby768my-Endur-800x450-1.jpg https://cancernetus.com/product/biosimilars-implications-for-clinical-practice-in-hematological-malignancies-supportive-care-enduring-webcast/ 2025-10-22T18:28:28+00:00 https://cancernetus.com/wp-content/uploads/2025/08/kdm0lnmyxr9z-OverviewPg800x450.jpg https://cancernetus.com/product/update-on-the-immune-checkpoint-inhibitor-and-combination-targeted-therapies-for-hepatocellular-carcinoma/ 2025-10-22T18:28:52+00:00 https://cancernetus.com/wp-content/uploads/2021/02/pjz4qfzqnxl6-Norton_June25_Opportunistic_800x385-1.jpg https://cancernetus.com/product/changing-landscape-of-nsclc-with-targeted-therapies-and-immunotherapy/ 2025-10-22T18:29:04+00:00 https://cancernetus.com/wp-content/uploads/2020/11/GettyImages-2182528876-1.jpg https://cancernetus.com/product/advances-in-the-treatment-of-dmmr-msi-h-colorectal-cancer-with-immunotherapy/ 2025-10-22T18:29:13+00:00 https://cancernetus.com/wp-content/uploads/2020/11/GettyImages-2161167271-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-multiple-myeloma-2/ 2025-10-22T18:29:24+00:00 https://cancernetus.com/wp-content/uploads/2020/10/GettyImages-2155039605-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-hematological-malignancies/ 2025-10-22T18:29:32+00:00 https://cancernetus.com/wp-content/uploads/2020/09/GettyImages-485223216-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-renal-cell-carcinoma/ 2025-10-22T18:29:40+00:00 https://cancernetus.com/wp-content/uploads/2020/08/GettyImages-1635459952-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-lung-cancer-and-head-neck-cancer/ 2025-10-22T18:29:47+00:00 https://cancernetus.com/wp-content/uploads/2020/07/GettyImages-1403226796-1.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-carcinoma/ 2025-10-22T18:29:53+00:00 https://cancernetus.com/wp-content/uploads/2020/06/GettyImages-1315002704-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-metastatic-urothelial-carcinoma/ 2025-10-22T18:30:04+00:00 https://cancernetus.com/wp-content/uploads/2025/08/59xtmojglf5i-7084-Advances-in-Treatment-of-Urothelial-Carcinoma.jpg https://cancernetus.com/product/new-paradigms-in-the-treatment-of-relapsed-multiple-myeloma/ 2025-10-22T18:30:11+00:00 https://cancernetus.com/wp-content/uploads/2025/08/awbn5h3glq9c-7062-New-Paradigms-in-the-Treatment-of-Relapsed-Multiple-Myeloma.jpg https://cancernetus.com/product/new-paradigms-in-the-treatment-options-for-all-and-aml-european-perspective/ 2025-10-22T18:30:19+00:00 https://cancernetus.com/wp-content/uploads/2025/08/zjzpm7rc6man-7061-New-Paradigms-in-the-Treatment-Options-for-ALL-and-AML-European-Perspective.jpg https://cancernetus.com/product/current-and-emerging-treatment-options-for-lung-cancer-and-head-neck-carcinoma/ 2025-10-22T18:30:24+00:00 https://cancernetus.com/wp-content/uploads/2025/08/ua7p2kbz7wx1-6405-Current-and-Emerging-Treatment-Options-for-Lung-Cancer-and-Head-_-Neck-Carcinoma.jpg https://cancernetus.com/product/changing-landscape-of-treatment-of-hr-and-her2-metastatic-breast-cancer-with-pi3k-and-cdk-4-6-inhibitors/ 2025-10-22T18:30:35+00:00 https://cancernetus.com/wp-content/uploads/2025/08/d7c2dnhwyoar-6378-Changing-Landscape-of-Treatment-of-HR-and-HER2-Metastatic-Breast-Cancer-with-PI3K-and-CDK-4-6-Inhibitors.jpg https://cancernetus.com/product/changing-landscape-of-treatment-options-for-all-with-cd19-cd22-monoclonal-antibodies-and-aml-with-idh1-2-flt3-cd33-and-hedgehog-pathway-targeted-agents/ 2025-10-22T18:30:40+00:00 https://cancernetus.com/wp-content/uploads/2019/06/GettyImages-1790844523-1.jpg https://cancernetus.com/product/changing-landscape-of-therapies-for-urothelial-carcinoma-and-non-muscle-invasive-bladder-cancer-with-pd-1-pd-l1-inhibitors-adc-and-recombinant-adenovirus-mediated-interferon-a2b/ 2025-10-22T18:30:47+00:00 https://cancernetus.com/wp-content/uploads/2019/06/GettyImages-1790845584-1.jpg https://cancernetus.com/product/evolving-landscape-of-treatment-for-hepatocellular-carcinoma-with-multi-targeted-tyrosine-kinase-inhibitors-and-immunotherapy/ 2025-10-22T18:30:55+00:00 https://cancernetus.com/wp-content/uploads/2025/08/s8yofk4cgvel-ascohcclarge_1539592_800x433.png https://cancernetus.com/product/changing-landscape-of-targeted-and-immunotherapies-for-genitourinary-cancers/ 2025-10-22T18:31:05+00:00 https://cancernetus.com/wp-content/uploads/2025/08/vkn6rhhxs91c-gularge_1538479.jpg https://cancernetus.com/product/changing-treatment-landscape-of-metastatic-head-and-neck-squamous-cell-carcinoma-with-anti-pd-1-pd-l1-agents/ 2025-10-22T18:31:27+00:00 https://cancernetus.com/wp-content/uploads/2025/08/itm75xtdm6dz-cmlisdrivenbybcrabl1larg_1536907_800x433.jpg https://cancernetus.com/product/new-paradigms-in-the-treatment-of-acute-lymphoblastic-leukemia-chronic-lymphocytic-leukemia-acute-myeloid-leukemia-and-chronic-myeloid-leukemia-module-2/ 2025-10-22T18:31:33+00:00 https://cancernetus.com/wp-content/uploads/2025/08/itm75xtdm6dz-cmlisdrivenbybcrabl1larg_1536907_800x433.jpg https://cancernetus.com/product/new-paradigms-in-the-treatment-of-acute-lymphoblastic-leukemia-chronic-lymphocytic-leukemia-acute-myeloid-leukemia-and-chronic-myeloid-leukemia-module-1/ 2025-10-22T18:31:41+00:00 https://cancernetus.com/wp-content/uploads/2025/08/2lgmux20pqbs-cmlisdrivenbybcrabl1larg_1536899_800x433.jpg https://cancernetus.com/product/update-on-treatment-options-for-acute-lymphoblastic-leukemia-with-an-emphasis-on-cd19-cd22-monoclonal-antibodies-and-anti-cd19-car-t-cell-therapy/ 2025-10-22T18:32:00+00:00 https://cancernetus.com/wp-content/uploads/2018/12/GettyImages-953188648-1.jpg https://cancernetus.com/product/changing-landscape-of-treatment-strategies-of-tki-interruptions-discontinuations-and-switching-in-patients-with-chronic-myeloid-leukemia/ 2025-10-22T18:32:05+00:00 https://cancernetus.com/wp-content/uploads/2018/12/GettyImages-2173675916-1.jpg https://cancernetus.com/product/emerging-novel-pi3k-inhibitors-anti-cd20-mab-and-combination-therapy-options-for-follicular-lymphoma/ 2025-10-22T18:32:09+00:00 https://cancernetus.com/wp-content/uploads/2018/12/GettyImages-846421676-1.jpg https://cancernetus.com/product/optimizing-outcomes-in-patients-with-malignant-melanoma-treated-with-targeted-agents-checkpoint-inhibitors-and-oncolytic-viral-therapies/ 2025-10-22T18:32:15+00:00 https://cancernetus.com/wp-content/uploads/2018/12/GettyImages-1216939216-1.jpg https://cancernetus.com/product/changing-treatment-paradigms-with-immunotherapy-and-targeted-therapy-in-advanced-non-small-cell-lung-cancer-and-head-neck-cancer-2/ 2025-10-22T18:32:20+00:00 https://cancernetus.com/wp-content/uploads/2018/10/GettyImages-2164182674-1.jpg https://cancernetus.com/product/emerging-treatment-options-for-genomic-subgroups-of-acute-myeloid-leukemia-with-idh1-2-flt3-and-cd33-targeted-agents/ 2025-10-22T18:32:26+00:00 https://cancernetus.com/wp-content/uploads/2018/10/GettyImages-2152093002-1.jpg https://cancernetus.com/product/emerging-strategies-in-novel-targeted-therapies-for-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-bladder-carcinoma-2/ 2025-10-22T18:32:31+00:00 https://cancernetus.com/wp-content/uploads/2018/09/GettyImages-531195396-1.jpg https://cancernetus.com/product/mapping-the-current-and-future-treatment-options-for-advanced-soft-tissue-sarcoma-including-liposarcoma-and-leiomyosarcoma/ 2025-10-22T18:32:41+00:00 https://cancernetus.com/wp-content/uploads/2018/08/GettyImages-1409385302-1.jpg https://cancernetus.com/product/mapping-the-future-treatment-options-with-multitargeted-tkis-and-checkpoint-inhibitors-for-metastatic-renal-cell-carcinoma/ 2025-10-22T18:32:49+00:00 https://cancernetus.com/wp-content/uploads/2018/08/GettyImages-2196144763-1.jpg https://cancernetus.com/product/emerging-novel-anti-cd20-mab-pi3k-inhibitors-and-combination-therapy-options-for-follicular-lymphoma/ 2025-10-22T18:32:54+00:00 https://cancernetus.com/wp-content/uploads/2018/08/GettyImages-2206943370-1.jpg https://cancernetus.com/product/7th-annual-symposium-on-current-strategies-in-the-treatment-of-hodgkins-lymphoma-b-cell-lymphoma-multiple-myeloma-and-leukemia-2/ 2025-10-22T18:33:01+00:00 https://cancernetus.com/wp-content/uploads/2018/06/GettyImages-2166267961-1.jpg https://cancernetus.com/product/immunotherapy-with-anti-pd-1-pd-l1-agents-are-new-effective-therapies-for-recurring-and-or-metastatic-squamous-cell-carcinoma-of-the-head-and-neck/ 2025-10-22T18:33:10+00:00 https://cancernetus.com/wp-content/uploads/2018/06/GettyImages-2212054265-1-scaled.jpg https://cancernetus.com/product/advances-in-the-treatment-of-acute-lymphoblastic-leukemia-with-an-emphasis-on-cd22-and-cd19-monoclonal-antibodies/ 2025-10-22T18:33:17+00:00 https://cancernetus.com/wp-content/uploads/2018/04/GettyImages-2151620892-1.jpg https://cancernetus.com/product/emerging-treatment-options-for-chronic-lymphocytic-leukemia-and-mantle-cell-lymphoma/ 2025-10-22T18:35:38+00:00 https://cancernetus.com/wp-content/uploads/2025/08/g9k9gj000gdz-800x450-1.jpg https://cancernetus.com/product/changing-landscape-of-diagnosis-and-treatment-options-for-multiple-myeloma-enduring-webcast/ 2025-10-22T18:35:51+00:00 https://cancernetus.com/wp-content/uploads/2025/08/fzlsw2ojc1ih-Oveview800x450_Endur.jpg https://cancernetus.com/product/myelofibrosis-symptom-burden-risk-stratification-and-novel-treatments-enduring-webcast/ 2025-10-22T18:36:01+00:00 https://cancernetus.com/wp-content/uploads/2025/08/gjl0exwzk37p-Banner800x450_Endur.png https://cancernetus.com/product/emerging-strategies-in-the-management-of-genitourinary-cancers-live/ 2025-10-22T18:39:44+00:00 https://cancernetus.com/wp-content/uploads/2025/08/pcglzlzgc5w8-OveviewPg_800x450.png https://cancernetus.com/product/emerging-strategies-in-the-management-of-genitourinary-cancers-prostate-cancer-renal-cell-carcinoma-and-urothelial-carcinoma-enduring/ 2025-10-22T18:40:13+00:00 https://cancernetus.com/wp-content/uploads/2025/08/o8roggebnotq-Oveview-page-800x450-1.jpg https://cancernetus.com/product/changing-landscape-of-diagnosis-and-personalized-therapies-for-acute-myeloid-leukemia-enduring-webcast/ 2025-10-22T18:41:31+00:00 https://cancernetus.com/wp-content/uploads/2025/08/3b4qgiydhn8r-AML_800x450.png https://cancernetus.com/product/changing-landscape-of-dlbcl-treatment-adcs-bispecific-antibodies-car-t-therapies-and-combinations-live-copy/ 2025-10-23T15:52:02+00:00 https://cancernetus.com/wp-content/uploads/2025/10/800-x-450.png https://cancernetus.com/product/changing-landscape-of-dlbcl-treatment-adcs-bispecific-antibodies-car-t-therapies-and-combinations-enduring-webcast/ 2025-10-27T19:49:08+00:00 https://cancernetus.com/wp-content/uploads/2025/10/Enduring-800-x-450-1.png https://cancernetus.com/product/7th-annual-symposium-on-current-strategies-in-the-treatment-of-hodgkins-lymphoma-b-cell-lymphoma-multiple-myeloma-and-leukemia/ 2025-12-17T09:44:14+00:00 https://cancernetus.com/wp-content/uploads/2018/06/GettyImages-1632998634.webp https://cancernetus.com/product/advances-in-the-treatment-of-myelofibrosis-clinical-trial-data-of-next-generation-therapeutics/ 2025-12-23T20:01:57+00:00 https://cancernetus.com/wp-content/uploads/2025/12/MF-800-x-450-enduring.png https://cancernetus.com/product/evolving-strategies-in-the-diagnosis-and-treatment-of-muscle-invasive-bladder-cancer-live/ 2026-01-12T14:10:21+00:00 https://cancernetus.com/wp-content/uploads/2026/01/800x450.png https://cancernetus.com/product/changing-landscape-of-dlbcl-treatment-adcs-bispecific-antibodies-car-t-therapies-and-combinations-live/ 2026-03-17T07:17:40+00:00 https://cancernetus.com/wp-content/uploads/2025/08/87on8jiwec1a-800x450-1.png https://cancernetus.com/product/pi3k-akt-mtor-pathway-inhibitors-in-the-treatment-of-hr-her2-metastatic-breast-cancer/ 2026-03-17T07:18:13+00:00 https://cancernetus.com/wp-content/uploads/2025/08/97nnoucvkn3k-W26-55B_800x450.png https://cancernetus.com/product/changing-landscape-of-diagnosis-and-personalized-therapies-for-acute-myeloid-leukemia-2-live/ 2026-03-17T07:22:07+00:00 https://cancernetus.com/wp-content/uploads/2025/08/ocbjk5nmgl4b-Banner800x450.png https://cancernetus.com/product/advances-in-the-treatment-of-diffuse-large-b-cell-lymphoma-adcs-bispecific-antibodies-car-t-therapies-and-combinations-2-live/ 2026-03-17T07:22:40+00:00 https://cancernetus.com/wp-content/uploads/2025/08/mdnd7aozny1g-Banner800x450.png https://cancernetus.com/product/myelofibrosis-symptom-burden-risk-stratification-and-novel-treatments-2-live/ 2026-03-17T07:23:48+00:00 https://cancernetus.com/wp-content/uploads/2025/08/twb2i66v238d-Banner800x450.png https://cancernetus.com/product/changing-landscape-of-diagnosis-and-treatment-of-multiple-myeloma-live/ 2026-03-17T07:24:20+00:00 https://cancernetus.com/wp-content/uploads/2025/08/fdxpf4qs7jzr-OveviewPg800x450.png